Selected research
Industry Research
Bicyclic Peptide Industry Research Report 2026
Market perspective
The global Bicyclic Peptide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bicyclic Peptide is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bicyclic Peptide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bicyclic Peptide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bicyclic Peptide include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bicyclic Peptide market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Bicyclic Peptide.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bicyclic Peptide Market by Company
Creative Peptides
Genscript
JPT Peptide Technologies
Hongtide
Bicyclic Peptide Segment by Type
Heterocyclic Bicyclic Peptides
Homocyclic Bicyclic Peptides
Bicyclic Peptide Segment by Application
Neurogenic Activity
Antibacterial
Antitumor
Other
Bicyclic Peptide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicyclic Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bicyclic Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicyclic Peptide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bicyclic Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bicyclic Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bicyclic Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Heterocyclic Bicyclic Peptides
- Homocyclic Bicyclic Peptides
Applications
- Neurogenic Activity
- Antibacterial
- Antitumor
- Other
Companies covered
- Creative Peptides
- Genscript
- JPT Peptide Technologies
- Hongtide
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bicyclic Peptide by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Heterocyclic Bicyclic Peptides
- 2.2.3 Homocyclic Bicyclic Peptides
- 2.3 Bicyclic Peptide by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Neurogenic Activity
- 2.3.3 Antibacterial
- 2.3.4 Antitumor
- 2.3.5 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Bicyclic Peptide Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Bicyclic Peptide Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Bicyclic Peptide Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Bicyclic Peptide Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bicyclic Peptide Production by Manufacturers (2021-2026)
- 3.2 Global Bicyclic Peptide Production Value by Manufacturers (2021-2026)
- 3.3 Global Bicyclic Peptide Average Price by Manufacturers (2021-2026)
- 3.4 Global Bicyclic Peptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bicyclic Peptide Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Bicyclic Peptide Manufacturers, Product Type & Application
- 3.7 Global Bicyclic Peptide Manufacturers Established Date
- 3.8 Global Bicyclic Peptide Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Creative Peptides
- 4.1.1 Creative Peptides Bicyclic Peptide Company Information
- 4.1.2 Creative Peptides Bicyclic Peptide Business Overview
- 4.1.3 Creative Peptides Bicyclic Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Creative Peptides Product Portfolio
- 4.1.5 Creative Peptides Recent Developments
- 4.2 Genscript
- 4.2.1 Genscript Bicyclic Peptide Company Information
- 4.2.2 Genscript Bicyclic Peptide Business Overview
- 4.2.3 Genscript Bicyclic Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Genscript Product Portfolio
- 4.2.5 Genscript Recent Developments
- 4.3 JPT Peptide Technologies
- 4.3.1 JPT Peptide Technologies Bicyclic Peptide Company Information
- 4.3.2 JPT Peptide Technologies Bicyclic Peptide Business Overview
- 4.3.3 JPT Peptide Technologies Bicyclic Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 JPT Peptide Technologies Product Portfolio
- 4.3.5 JPT Peptide Technologies Recent Developments
- 4.4 Hongtide
- 4.4.1 Hongtide Bicyclic Peptide Company Information
- 4.4.2 Hongtide Bicyclic Peptide Business Overview
- 4.4.3 Hongtide Bicyclic Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Hongtide Product Portfolio
- 4.4.5 Hongtide Recent Developments
5 Global Bicyclic Peptide Production by Region
- 5.1 Global Bicyclic Peptide Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bicyclic Peptide Production by Region: 2021-2032
- 5.2.1 Global Bicyclic Peptide Production by Region: 2021-2026
- 5.2.2 Global Bicyclic Peptide Production Forecast by Region (2027-2032)
- 5.3 Global Bicyclic Peptide Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Bicyclic Peptide Production Value by Region: 2021-2032
- 5.4.1 Global Bicyclic Peptide Production Value by Region: 2021-2026
- 5.4.2 Global Bicyclic Peptide Production Value Forecast by Region (2027-2032)
- 5.5 Global Bicyclic Peptide Market Price Analysis by Region (2021-2026)
- 5.6 Global Bicyclic Peptide Production and Value, YOY Growth
- 5.6.1 North America Bicyclic Peptide Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Bicyclic Peptide Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Bicyclic Peptide Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Bicyclic Peptide Production Value Estimates and Forecasts (2021-2032)
6 Global Bicyclic Peptide Consumption by Region
- 6.1 Global Bicyclic Peptide Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bicyclic Peptide Consumption by Region (2021-2032)
- 6.2.1 Global Bicyclic Peptide Consumption by Region: 2021-2026
- 6.2.2 Global Bicyclic Peptide Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bicyclic Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bicyclic Peptide Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Bicyclic Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bicyclic Peptide Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bicyclic Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bicyclic Peptide Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 China Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Bicyclic Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Bicyclic Peptide Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Bicyclic Peptide Production by Type (2021-2032)
- 7.1.1 Global Bicyclic Peptide Production by Type (2021-2032) & (Kg)
- 7.1.2 Global Bicyclic Peptide Production Market Share by Type (2021-2032)
- 7.2 Global Bicyclic Peptide Production Value by Type (2021-2032)
- 7.2.1 Global Bicyclic Peptide Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Bicyclic Peptide Production Value Market Share by Type (2021-2032)
- 7.3 Global Bicyclic Peptide Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Bicyclic Peptide Production by Application (2021-2032)
- 8.1.1 Global Bicyclic Peptide Production by Application (2021-2032) & (Kg)
- 8.1.2 Global Bicyclic Peptide Production Market Share by Application (2021-2032)
- 8.2 Global Bicyclic Peptide Production Value by Application (2021-2032)
- 8.2.1 Global Bicyclic Peptide Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Bicyclic Peptide Production Value Market Share by Application (2021-2032)
- 8.3 Global Bicyclic Peptide Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Bicyclic Peptide Value Chain Analysis
- 9.1.1 Bicyclic Peptide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Bicyclic Peptide Production Mode & Process
- 9.2 Bicyclic Peptide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bicyclic Peptide Distributors
- 9.2.3 Bicyclic Peptide Customers
10 Global Bicyclic Peptide Analyzing Market Dynamics
- 10.1 Bicyclic Peptide Industry Trends
- 10.2 Bicyclic Peptide Industry Drivers
- 10.3 Bicyclic Peptide Industry Opportunities and Challenges
- 10.4 Bicyclic Peptide Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst